Respiratory Medicine
Volume 97, Issue 1 , Pages 65-70 , January 2003

Management of multiple drug-resistant tuberculosis

  • D.C.S HUTCHISON

      Affiliations

    • Department of Respiratory Medicine, King's College Hospital, London, U.K.
  • ,
  • F.A DROBNIEWSKI

      Affiliations

    • PHLS Mycobacterium Reference Unit and Department of Respiratory Medicine, King's College Hospital, London, U.K.
  • ,
  • H.J MILBURN

      Affiliations

    • Department of Respiratory Medicine, Guy's and St Thomas' Hospitals, London, U.K.

Received 5 February 2002 ,Accepted 29 May 2002.

References 

    REFERENCES
  1. Espinal MA, Laszlo A, Simonsen L. Global trends in resistance to antituberculosis drugs. N Engl J Med. 2001;344:1294–1303
  2. Fujiwara PI, Cook SV, Rutherford CM. A continuing survey of drug-resistant tuberculosis, New York City, April 1994. Arch Intern Med. 1997;157:531–536
  3. Irish C, Herbert J, Bennett D. Database study of antibiotic resistant tuberculosis in the United Kingdom, 1994-6. Br Med J. 1999;318:497–498
  4. Public Health Laboratory Service, Communicable Disease Surveillance Centre, www.phls.co.uk
  5. Balogun MA, Wall PG, Noone A. Undernotification of tuberculosis in patients with AIDS. Int J STD AIDS. 1995;7:58–60
  6. Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampicin. N Engl J Med. 1993;328:527–532
  7. Telzak EE, Sepkowitz K, Alpert P, Mannheimer S, Medard F, El-Sadr W. Multidrug-resistant tuberculosis in patients without HIV infection. N Engl J Med. 1995;333:907–911
  8. Helbling P, Altpeter E, Raeber P-A, Pfyffer GE, Zellweger J-P. Surveillance of antituberculosis drug resistance in Switzerland 1995–1997: the central link. Eur Resp J. 2000;16:200–202
  9. Thomsen VO, Bauer J, Lillebaek T, Glismann S. Results from 8 yrs of susceptibility testing of clinical Mycobacterium tuberculosis isolates in Denmark. Eur Resp J. 2000;15:203–208
  10. Schwoebel V, Decludt B, de Benoist A-C. Multidrug resistant tuberculosis in France 1992–1994: two case-control studies. Br Med J. 1998;317:630–631
  11. Borchardt J, Kirsten D, Jorres R, Kroeger C, Magnussen H. Drug-resistant tuberculosis in Northern Germany: a retrospective hospital-based study of 1,055 patients from 1984 until 1993. Eur Resp J. 1995;8:1076–1083
  12. Mahmoudi A, Iseman MD. Pitfalls in the care of patients with tuberculosis. JAMA. 1993;270:65–68
  13. Iseman MD. Treatment of multidrug-resistant tuberculosis. N Engl J Med. 1993;329:784–791
  14. Espinal MA, Laserson K, Camacho M. Determinants of drug-resistant tuberculosis: analysis of countries. Int J Tuberc Lung Dis. 2001;5:887–893
  15. Park SK, Kim CT, Song SD. Outcome of chemotherapy in 107 patients with pulmonary TB resistant to isoniazid and rifampicin. Int J Tuberc Lung Dis. 1998;2:877–884
  16. Mitchison DA, Nunn AJ. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis. 1986;133:423–430
  17. Thorax. 1998;53:536–548
  18. Iseman MD. Management of multidrug-resistant tuberculosis. Chemotherapy. 1999;45:3–11
  19. Espinal MA, Kim SJ, Suarez PG. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA. 2000;283:2537–2545
  20. Farmer P, Kim JY. Community based approaches to the control of multidrug resistant tuberculosis: introducing “DOTS-plus”. Br Med J. 1998;317:671–674
  21. Heifets LB, Cangelosi GA. Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century. Int J Tuberc Lung Dis. 1999;3:564–581
  22. Drobniewski FA. Diagnosing multidrug resistant tuberculosis in Britain. Br Med J. 1998;317:1263–1264
  23. Drobniewski F, Hutchison D CS. Multiple-drug-resistant tuberculosis. In:  Finch RG editors. Bailliere's Clinical Infectious Diseases. 5:London: Baillére Tindall; 1999;

PII: S0954-6111(02)91412-5

doi: 10.1053/rmed.2002.1412

Respiratory Medicine
Volume 97, Issue 1 , Pages 65-70 , January 2003